A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer

Proteomics - Clinical Applications

Volumn 8, Issue 9-10, 2014, Pages 773-782

  Yang, Ting ^a   Xu, Feifei ^a   Zhao, Yi ^b   Wang, Shui ^b   Yang, Mi ^c   Chen, Yun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Breast cancer cells and tissue; Human transferrin receptor; Liquid chromatography tandem mass spectrometry; Method development; Targeted proteomics

Indexed keywords

MEMBRANE PROTEIN; TRANSFERRIN RECEPTOR;

ACCURACY; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BREAST CANCER; BREAST CELL; CLINICAL PRACTICE; CONTROLLED STUDY; EARLY DIAGNOSIS; ELECTROSPRAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; BREAST TUMOR; CHEMISTRY; FEMALE; METABOLISM; MOLECULAR GENETICS; PROCEDURES; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEOMICS; RECEPTORS, TRANSFERRIN; TANDEM MASS SPECTROMETRY;

EID: 84908028831     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300109     Document Type: Article

References (47)

1. Kelter, G., Steinbach, D., Konkimalla, V. B., Tahara, T. et al., Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS One 2007, 2, e798.
2. Walker, R. A., Day, S. J., Transferrin receptor expression in non-malignant and malignant human breast tissue. J. Pathol. 1986, 148, 217-224.
3. Habashy, H., Powe, D., Staka, C., Rakha, E. et al., Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res. Treatment 2010, 119, 283-293.
4. Barabas, K., Faulk, W. P., Transferrin receptors associate with drug resistance in cancer cells. Biochem. Biophys. Res. Commun. 1993, 197, 702-708.
5. Li, H., Qian, Z. M., Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev. 2002, 22, 225-250.
6. Qian, Z. M., Li, H., Sun, H., Ho, K., Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 2002, 54, 561-587.
7. Jhaveri, M. S., Rait, A. S., Chung, K. N., Trepel, J. B., Chang, E. H., Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment. Mol. Cancer. Ther. 2004, 3, 1505-1512.
8. Yin, J., Lin, A. J., Buckett, P. D., Wessling-Resnick, M. et al., Single-cell FRET imaging of transferrin receptor trafficking dynamics by Sfp-catalyzed, site-specific protein labeling. Chem. Biol. 2005, 12, 999-1006.
9. Högemann-Savellano, D., Bos, E., Blondet, C., Sato, F. et al., The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia. 2003, 5, 495-506.
10. Method of the Year 2012. Nat. Methods 2013, 10, 1.
11. Vermeulen, J. F., van Brussel, A. S., van der Groep, P., Morsink, F. H. et al., Immunophenotyping invasive breast cancer: paving the road for molecular imaging. BMC Cancer 2012, 12, 240-249.
12. Shaner, N. C., Lin, M. Z., McKeown, M. R., Steinbach, P. A. et al., Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat. Methods 2008, 5, 545-551.
13. Cox, J., Mann, M., Quantitative, high-resolution proteomics for data-driven systems biology. Annu. Rev. Biochem. 2012, 80, 273-299.
14. Schoenherr, R. M., Whiteaker, J. R., Zhao, L., Ivey, R. G. et al., Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry. Proteomics 2012, 12, 1253-1260.
15. Calvo, E., Camafeita, E., Fernandez-Gutierrez, B., Lopez, J. A., Applying selected reaction monitoring to targeted proteomics. Expert Rev. Proteomics 2011, 8, 165-173.
16. Balogh, L. M., Kimoto, E., Chupka, J., Zhang, H., Lai, Y., membrane protein quantification by peptide-based mass spectrometry approaches: studies on the organic anion-transporting polypeptide family. Proteomics Bioinformatics 2012, S4, 1-8.
17. Kiyonami, R., Schoen, A., Prakash, A., Peterman, S. et al., Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol. Cell. Proteomics 2011, 10, M110 002931.
18. Pryde, J. G., Partitioning of Proteins in Triton X-114, Humana Press Inc., NJ 1998.
19. Yang, T., Xu, F., Xu, J., Fang, D. et al., Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of p-glycoprotein in human breast cancer cells. J. Chromatogr. B 2013, 936, 18-24.
20. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
21. http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf, Guidance for Industry: Bioanalytical Method Validation. U.S. Department of Health and Human Services, Food and Drug Administration 2001.
22. Li, N., Palandra, J., Nemirovskiy, O. V., Lai, Y., LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species. Anal. Chem. 2009, 81, 2251-2259.
23. Barnidge, D. R., Dratz, E. A., Martin, T., Bonilla, L. E. et al., Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem. 2003, 75, 445-451.
24. Seddon, A. M., Curnow, P., Booth, P. J., Membrane proteins, lipids and detergents: not just a soap opera. Biochim. Biophys. Acta 2004, 1666, 105-117.
25. Arnold, T., Linke, D., The use of detergents to purify membrane proteins. Curr. Protoc. Protein Sci. 2008, 53, 4.8.1-4.8.30.
26. Bordier, C., Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 1981, 256, 1604-1607.
27. Crother, T. R., Nally, J. E., Analysis of bacterial membrane proteins produced during mammalian infection using hydrophobic antigen tissue triton extraction (HATTREX). Curr. Protoc. Microbiol. 2008, 9, 12.1.1-12.1.5.
28. Mathias, R. A., Chen, Y. S., Kapp, E. A., Greening, D. W. et al., Triton X-114 phase separation in the isolation and purification of mouse liver microsomal membrane proteins. Methods 2011, 54, 396-406.
29. Deutsch, E. W., Lam, H., Aebersold, R., PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep. 2008, 9, 429-434.
30. Becker, J. O., Hoofnagle, A. N., Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. Bioanalysis 2012, 4, 281-290.
31. Elschenbroich, S., Kislinger, T., Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol. Biosyst. 2011, 7, 292-303.
32. MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M. et al., Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26, 966-968.
33. Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K. et al., Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm. Res. 2008, 25, 1469-1483.
34. Uchida, Y., Tachikawa, M., Obuchi, W., Hoshi, Y. et al., A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice. Fluids Barriers CNS 2013, 10, 21-42.
35. Kuzyk, M. A., Smith, D., Yang, J., Cross, T. J. et al., Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 2009, 8, 1860-1877.
36. Yu, Y., Xu, J., Liu, Y., Chen, Y., Quantification of human serum transferrin using liquid chromatography-tandem mass spectrometry based targeted proteomics. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2012, 902, 10-15.
37. Kuhn, E., Wu, J., Karl, J., Liao, H. et al., Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
38. Wind, T. C., Messenger, M. P., Thompson, D., Selby, P. J., Banks, R. E., Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions. Ann. Clin. Biochem. 48, 112-120.
39. Delaunay-Bertoncini, N., Pichon, V., Hennion, M. C., Experimental comparison of three monoclonal antibodies for the class-selective immunoextraction of triazines. Correlation with molecular modeling and principal component analysis studies. J. Chromatogr. A 2003, 999, 3-15.
40. Heidebrecht, F., Heidebrecht, A., Schulz, I., Behrens, S. E., Bader, A., Improved semiquantitative Western blot technique with increased quantification range. J. Immunol. Methods 2009, 345, 40-48.
41. Uchida, M., Hanai, S., Uematsu, N., Sawamoto, K. et al., Overexpression of poly(ADP-ribose) polymerase disrupts organization of cytoskeletal F-actin and tissue polarity in Drosophila. J. Biol. Chem. 2002, 277, 6696-6702.
42. Porsch-Ozcurumez, M., Kischel, N., Priebe, H., Splettstosser, W. et al., Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia. Clin. Diagn. Lab. Immunol. 2004, 11, 1008-1015.
43. Harris, L., Fritsche, H., Mennel, R., Norton, L. et al., American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 2007, 25, 5287-5312.
44. Singh, M., Mugler, K., Hailoo, D. W., Burke, S. et al., Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma. Appl. Immunohistochem. Mol. Morphol. 2011, 19, 417-423.
45. Guerra, I., Algorta, J., Diaz de Otazu, R., Pelayo, A., Farina, J., Immunohistochemical prognostic index for breast cancer in young women. Mol. Pathol. 2003, 56, 323-327.
46. Galea, M. H., Blamey, R. W., Elston, C. E., Ellis, I. O., The Nottingham Prognostic Index in primary breast cancer. Breast Cancer. Res. Treat. 1992, 22, 207-219.
47. Ndao, M., Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry. Methods Mol. Biol. 2012, 818, 67-79.